Mesothelioma Lawyers: Helping Victims of Asbestos Cancer

Mesothelioma is a malignant cancer that can start in the cavities of the lungs, the heart, or the abdomen. Most mesothelioma patients were exposed to asbestos on jobsites where the parties in charge were well aware of the dangers of asbestos inhalation and exposure. Mesothelioma Lawyers: Helping Victims of Asbestos Cancer. Mesothelioma Lawyers tend to charge fees in advance for the preparation and trial. This cancer is the direct result of exposure to disturbed asbestos, where the fibers become airborne. Do take time to interview a number of Mesothelioma Lawyers before setting your eyes on one in particular. Under the law, mesothelioma victims and their families are eligible to file suit against negligent parties to recover compensation for their damages. Remember : Many people who develop mesothelioma due to asbestos exposure may be eligible for compensation.

Mesothelioma Lawyers: Helping Victims of Asbestos Cancer

If you or someone you love has been diagnosed with mesothelioma, an attorney from Shrader & Associates, LLP can help you build a strong case. While there is no way to compensate for the loss of your health due to mesothelioma, we can help you recover compensation to help with the cost of care and other expenses. Each mesothelioma lawyer at our firm has been defending the rights of mesothelioma cancer and asbestos exposure victims for years. We know how devastating a mesothelioma diagnosis is for victims and their families, and we will always treat our clients with the dignity and respect they deserve.

Contact a Mesothelioma Lawyer

To learn more, contact a mesothelioma attorney at Shrader & Associates, LLP by filling out the small form above. A member of our team will contact you shortly to listen to your story and discuss your legal options.

Aromasin drug prevented 65% of women that is already being used to

Those at risk for breast cancer may have a new way to prevent the disease: a drug that is already being used to treat it.

According to CNN, researchers have stated that the estrogen-blocking drug Aromasin prevented 65% of women in a clinical trial from contracting breast cancer. Their study, which has been published in the New England Journal of Medicine, enrolled 4,560 health postmenopausal women at high risk for developing breast cancer. The significant reduction in risk was found after the women had been taking the drug for three years. The research continues as longer-term effects are measured.

Aromasin is an aromatase inhibitor drug, meaning that it blocks the production of estrogen in postmenopausal women. Estrogen has been implicated in facilitating the growth of breast cancer in older women.

Dr. Jennifer Litton, a breast cancer specialist at the MD Anderson Cancer Center in Houston, said that other drugs she prescribes often scare away patients because of their side effects, which include rare cases of uterine cancer. "This is the first study to show that a new class of drugs, aromatase inhibitors, have the ability to prevent breast cancer in high-risk women," she said, adding that she is hopeful Aromasin, which has fewer side-effects, will prove an attractive option to such women.

While the study results showed no serious toxic effects from the drug, doctors like Jose Baselga of Massachusetts General's Cancer Center caution against ignoring the risks involved. Aromatase inhibitor side effects include hot flashes, arthritis, and bone loss. As for prescribing Aromasin, “I would limit it to patients who have very high risks" for getting breast cancer, Baselga said.